Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Geftib Gefitinib 250 Mg Tablets

  • Product Name : Geftib Gefitinib 250 Mg Tablets
  • Category : Tablet
  • Manufacturer Name : Glenmark
  • Trade Name : Geftib
  • Available Dosage : 250 MG
  • Packing : Box
  • Pack Insert/Leaflet : Box/10*10 Tablets
  • Ingredients : Gefitinib
  • Formulation : Tablet
  • Therapeutic use :
  • Production Capacity : 100000

Description:-

Introduction to Geftib Gefitinib 250 Mg Tablets:

Geftib Gefitinib 250 mg Tablets are essential for treating advanced stages of non-small cell lung cancer, providing effective management and improved quality of life for patients.


Uses of Geftib Gefitinib 250 Mg Tablets:

Geftib Gefitinib 250 mg Tablets are used for:

  • Treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body
  • Management of cancer symptoms and progression


Benefits of Geftib Gefitinib 250 Mg Tablets:

  • Helps in shrinking tumors and slowing cancer growth
  • Improves symptoms such as difficulty breathing and chest pain
  • Enhances overall survival rates in patients with advanced NSCLC


Mechanism of Action of Geftib Gefitinib 250 Mg Tablets:

Gefitinib in Geftib Gefitinib 250 mg Tablets selectively inhibits the activity of epidermal growth factor receptor (EGFR) tyrosine kinase, which is often overactive in NSCLC cells.

By blocking EGFR signaling, Gefitinib helps to suppress cancer cell growth and proliferation.